Prelude Therapeutics, Inc. (PRLD)
3.89
+0.01
(+0.26%)
USD |
NASDAQ |
Oct 09, 16:00
3.96
+0.07
(+1.80%)
After-Hours: 20:00
Prelude Therapeutics Price to Book Value : 2.32 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.32 |
| October 08, 2026 | 2.314 |
| October 07, 2026 | 2.284 |
| October 06, 2026 | 2.272 |
| October 05, 2026 | 2.248 |
| October 02, 2026 | 2.189 |
| October 01, 2026 | 2.260 |
| September 30, 2026 | 2.332 |
| September 29, 2026 | 2.362 |
| September 28, 2026 | 2.332 |
| September 25, 2026 | 2.311 |
| September 24, 2026 | 2.380 |
| September 23, 2026 | 2.570 |
| September 22, 2026 | 2.892 |
| September 21, 2026 | 2.803 |
| September 18, 2026 | 2.904 |
| September 17, 2026 | 2.726 |
| September 16, 2026 | 2.666 |
| September 15, 2026 | 2.696 |
| September 14, 2026 | 2.737 |
| September 11, 2026 | 2.737 |
| September 10, 2026 | 2.785 |
| September 09, 2026 | 3.036 |
| September 08, 2026 | 3.161 |
| September 04, 2026 | 3.256 |
| Date | Value |
|---|---|
| September 03, 2026 | 3.131 |
| September 02, 2026 | 3.238 |
| September 01, 2026 | 3.274 |
| August 31, 2026 | 3.340 |
| August 28, 2026 | 3.262 |
| August 27, 2026 | 3.781 |
| August 26, 2026 | 3.912 |
| August 25, 2026 | 3.930 |
| August 24, 2026 | 3.859 |
| August 21, 2026 | 3.954 |
| August 20, 2026 | 3.876 |
| August 19, 2026 | 3.447 |
| August 18, 2026 | 3.429 |
| August 17, 2026 | 3.358 |
| August 14, 2026 | 3.31 |
| August 13, 2026 | 3.197 |
| August 12, 2026 | 3.417 |
| August 11, 2026 | 3.173 |
| August 10, 2026 | 2.881 |
| August 07, 2026 | 2.922 |
| August 06, 2026 | 2.791 |
| August 05, 2026 | 2.708 |
| August 04, 2026 | 2.696 |
| August 03, 2026 | 2.618 |
| July 31, 2026 | 2.743 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Q32 Bio, Inc. | 1.869 |
| Intellia Therapeutics, Inc. | 2.515 |
| Twist Bioscience Corp. | 22.47 |
| Beam Therapeutics, Inc. | 2.486 |
| Revolution Medicines, Inc. | 15.60 |
Price to Book Value Related Metrics
| PS Ratio | 13.88 |
| Price | 3.89 |
| Earnings Yield | -20.25% |
| Market Cap | 310.26M |